Market Analysis

Real-time market data and insights.

📰 ATAI Latest News

Last Updated: AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder
GlobeNewsWire 2026-04-22 3:01 AM
AtaiBeckley: 'Buy' On New Key Developments For BPL-003 For TRD
SeekingAlpha 2026-04-08 7:54 PMhttps://seekingalpha.com/article/4876795-ataibeckley-inc-atai-discusses-positive-topline-results-from-exploratory-phase-iia-study-of?source=feed_all_articles" target="_blank" class="text-dark"> AtaiBeckley Inc. (ATAI) Discusses Positive Topline Results From Exploratory Phase IIa Study of EMP-01 in Social Anxiety Disorder - Slideshow
SeekingAlpha 2026-02-28 11:12 PM
AtaiBeckley Inc. (ATAI) Discusses Positive Topline Results From Exploratory Phase IIa Study of EMP-01 in Social Anxiety Disorder Transcript
SeekinSeekingAlpha 2026-02-27 11:57 AM
🔮
Keep Stock Illuminati Free

100% independent. Zero paywalls. Zero subscriptions.
Your support keeps the data flowing.

PayPal Donate via PayPal
☕ $5 📊 $10 🚀 $25

One-time or recurring — every dollar helps us add more data & features.

ATAI Tools
Dashboard Insider Trading Institutional SEC Filings Short Interest News Options
🔮
Keep Stock Illuminati Free

100% independent. Zero paywalls. Zero subscriptions.
Your support keeps the data flowing.

PayPal Donate via PayPal
☕ $5 📊 $10 🚀 $25

One-time or recurring — every dollar helps us add more data & features.

🔮
Keep Stock Illuminati Free

100% independent. Zero paywalls. Zero subscriptions.
Your support keeps the data flowing.

PayPal Donate via PayPal
☕ $5 📊 $10 🚀 $25

One-time or recurring — every dollar helps us add more data & features.